Literature DB >> 25728407

Safety evaluation of the human-identical milk monosaccharide, l-fucose.

Sharon S H Choi1, Barry S Lynch2, Nigel Baldwin3, Emily W Dakoulas4, Shambhu Roy4, Carey Moore5, Bjorn A Thorsrud5, Christoph H Röhrig6.   

Abstract

l-Fucose is a natural monosaccharide present in mammals where it is found predominantly as an O-glycosidically linked component of glycoproteins, glycolipids, and oligosaccharides. It is also present in its free form in human breast milk (human milk monosaccharide). l-Fucose plays important roles in the development of the immune and nervous systems and is involved in cognitive function and memory formation. The human-identical milk monosaccharide l-fucose is therefore proposed for use in infant formulas to better simulate the free saccharides present in human breast milk. As part of the safety evaluation of l-fucose, a subchronic dietary toxicity study preceded by an in utero phase was conducted in Sprague-Dawley rats. l-Fucose was without maternal toxicity or compound-related adverse effects on female reproduction and general growth and development of offspring at a maternal dietary level up to 1%, equivalent to a dose of 1655 mg/kg body weight (bw)/day. During the subchronic phase, no compound-related adverse effects were observed in first generation rats at dietary levels of up to 1% (highest level tested), corresponding to doses of 516 and 665 mg/kg bw/day in males and females, respectively. l-Fucose was non-genotoxic in a series of in vitro genotoxicity/mutagenicity tests. These results support the safe use of l-fucose in infant formula and as a food ingredient at levels equivalent to those present in human breast milk.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genotoxicity; Human milk monosaccharide; Infant formula; Subchronic toxicity; l-Fucose

Mesh:

Substances:

Year:  2015        PMID: 25728407     DOI: 10.1016/j.yrtph.2015.02.016

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  4 in total

1.  Carbocatalysed hydrolytic cleaving of the glycosidic bond in fucoidan under microwave irradiation.

Authors:  Elaine G Mission; Jonas Karl Christopher N Agutaya; Armando T Quitain; Mitsuru Sasaki; Tetsuya Kida
Journal:  RSC Adv       Date:  2019-09-25       Impact factor: 4.036

2.  Safety of 3-fucosyllactose (3-FL) produced by a derivative strain of Escherichia coli BL21 (DE3) as a Novel Food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Torsten Bohn; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Estefanía Noriega Fernández; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2022-05-25

3.  The Effects of Brown Algae-Derived Monosaccharide L-Fucose on Lipid Metabolism in C57BL/6J Obese Mice.

Authors:  Xiao Yuan; Tomohiko Nakao; Hina Satone; Kazuyuki Ohara; Yuri Kominami; Miho Ito; Teruki Aizawa; Tomoya Ueno; Hideki Ushio
Journal:  Nutrients       Date:  2020-12-11       Impact factor: 5.717

4.  Safety of 3-FL (3-Fucosyllactose) as a novel food pursuant to Regulation (EU) 2015/2283.

Authors:  Dominique Turck; Jacqueline Castenmiller; Stefaan De Henauw; Karen Ildico Hirsch-Ernst; John Kearney; Alexandre Maciuk; Inge Mangelsdorf; Harry J McArdle; Androniki Naska; Carmen Pelaez; Kristina Pentieva; Alfonso Siani; Frank Thies; Sophia Tsabouri; Marco Vinceti; Francesco Cubadda; Thomas Frenzel; Marina Heinonen; Rosangela Marchelli; Monika Neuhäuser-Berthold; Morten Poulsen; Miguel Prieto Maradona; Josef Rudolf Schlatter; Henk van Loveren; Paolo Colombo; Helle Katrine Knutsen
Journal:  EFSA J       Date:  2021-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.